Treace Medical Concepts, Inc. (TMCI)

NASDAQ: TMCI · IEX Real-Time Price · USD

5.00

-0.63 (-11.19%)

At close: May 17, 2024, 4:00 PM

5.01

+0.01 (0.20%)

After-hours: May 17, 2024, 7:59 PM EDT

Treace Medical Concepts Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	187.12	141.84	94.42	57.37	39.42
Revenue Growth (YoY)	31.92%	50.22%	64.59%	45.54%	-
Cost of Revenue	35.18	25.53	16.89	12.47	7.63
Gross Profit	151.94	116.31	77.53	44.9	31.79
Selling, General & Admin	187.93	137.57	83.84	38.19	30.25
Research & Development	15.44	13.58	10.2	5.85	5.07
Operating Expenses	203.37	151.15	94.04	44.04	35.32
Operating Income	-51.43	-34.84	-16.51	0.86	-3.54
Interest Expense / Income	5.17	4.4	4.06	2.78	0.84
Other Expense / Income	-7.07	3.57	-0.02	1.75	-0.11
Pretax Income	-49.53	-42.82	-20.55	-3.67	-4.27
Net Income	-49.53	-42.82	-20.55	-3.67	-4.27
Preferred Dividends	0	0	0.2	0.64	0.64
Net Income Common	-49.53	-42.82	-20.75	-4.31	-4.91
Shares Outstanding (Basic)	61	55	48	37	37
Shares Outstanding (Diluted)	61	55	48	37	37
Shares Change	10.09%	14.17%	30.61%	0.43%	-
EPS (Basic)	-0.81	-0.77	-0.43	-0.12	-0.13
EPS (Diluted)	-0.81	-0.77	-0.43	-0.12	-0.13
Free Cash Flow	-46.03	-45.49	-19.9	-5.56	-8.88
Free Cash Flow Per Share	-0.76	-0.82	-0.41	-0.15	-0.24
Gross Margin	81.20%	82.00%	82.11%	78.26%	80.64%
Operating Margin	-27.48%	-24.57%	-17.49%	1.49%	-8.97%
Profit Margin	-26.47%	-30.19%	-21.97%	-7.51%	-12.44%
Free Cash Flow Margin	-24.60%	-32.07%	-21.07%	-9.70%	-22.54%
EBITDA	-36.55	-33.76	-15.81	0.32	-2.63
EBITDA Margin	-19.53%	-23.80%	-16.74%	0.56%	-6.67%
Depreciation & Amortization	7.81	4.66	0.69	1.21	0.79
EBIT	-44.36	-38.42	-16.49	-0.89	-3.42
EBIT Margin	-23.71%	-27.09%	-17.47%	-1.55%	-8.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).